Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Analysis Predicting Prognosis of Intracranial Dissecting Aneurysm With Intramural Hematoma After Endovascular Treatment

NCT03940859 is registered in ClinicalTrials.gov with Beijing Neurosurgical Institute as lead sponsor.

NCT NCT03940859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03940859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Analysis Predicting Prognosis of Intracranial Dissecting Aneurysm With Intramural Hematoma After Endovascular Treatment
Lead sponsor
Beijing Neurosurgical Institute
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2019
Completion date
December 31, 2021
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dissecting aneurysm of cerebral artery